Pediatric Covid Vaccination: A Jab in Time Could Save Little Ones in their Prime!
Amrit Gopan
Citation Information :
Gopan A. Pediatric Covid Vaccination: A Jab in Time Could Save Little Ones in their Prime!. Ann Pediatr Gastroenterol Hepatol 2021; 3 (3):6-8.
Du Z, Wang L, Cauchemez S, et al. Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China. Emerg Infect Dis. 2020;26(5):1049-1052. doi: 10.3201/EID2605.200146
Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: A systematic review. E Clinical Medicine. 2020;24:100433. doi: 10.1016/j.eclinm.2020.100433
Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174(9):868-873. doi: 10.1001/jamapediatrics.2020.1948
HAN Archive - 00432 | Health Alert Network (HAN). Accessed August 7, 2021. https://emergency.cdc.gov/han/2020/han00432.asp
Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-1778. doi: 10.1016/S0140-6736(20)31103-X
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet (London, England). 2020;395(10237):1607-1608. doi: 10.1016/S0140-6736(20)31094-1
Gaythorpe KAM, Bhatia S, Mangal T, et al. Children's role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility. Sci Reports 2021 111. 2021;11(1):1-14. doi: 10.1038/s41598-021-92500-9
CDC COVID-19 response team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343-346. doi: 10.15585/MMWR.MM6912E2
Baden L, El Sahly H, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384(5):403-416. doi: 10.1056/NEJMOA2035389
Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-2615. doi: 10.1056/nejmoa2034577
Ella R, Vadrevu KM, Jogdand H, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021;21(5):637-646. doi: 10.1016/S1473-3099(20)30942-7
Cavaleri M, Enzmann H, Straus S, Cooke E. The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines. Lancet. 2021;397(10272):355-357. doi: 10.1016/S0140- 6736(21)00085-4
Krause PR, Gruber MF. Emergency Use Authorization of Covid Vaccines — Safety and Efficacy Follow-up Considerations. N Engl J Med. 2020;383(19):e107. doi: 10.1056/NEJMP2031373
Kaur U, Ojha B, Pathak BK, et al. A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers-first results from India. E Clinical Medicine. 2021;0(0):101038. doi: 10.1016/J.ECLINM.2021.101038
Frenck RW, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021;385(3):239-250. doi: 10.1056/nejmoa2107456
Li X, Xu W, Dozier M, et al. The Role of Children in the Transmission of SARS-CoV2: Updated Rapid Review. J Glob Health. 2020;10(2):1-11. doi: 10.7189/jogh.10.021101
Falk A, Benda A, Falk P, Steffen S, Wallace Z, Høeg TB. COVID-19 Cases and Transmission in 17 K–12 Schools — Wood County, Wisconsin, August 31–November 29, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(4):136-140. doi: 10.15585/mmwr.mm7004e3
Engzell P, Frey A, Verhagen MD. Learning loss due to school closures during the COVID-19 pandemic. Proc Natl Acad Sci USA. 2021;118(17). doi: 10.1073/PNAS.2022376118
Meherali S, Punjani N, Louie-Poon S, et al. Mental health of children and adolescents amidst covid-19 and past pandemics: A rapid systematic review. Int J Environ Res Public Health. 2021;18(7). doi: 10.3390/ijerph18073432
Chaffee BW, Cheng J, Couch ET, Hoeft KS, Halpern-Felsher B. Adolescents’ Substance Use and Physical Activity Before and During the COVID-19 Pandemic. JAMA Pediatr. 2021;175(7):715-722. doi: 10.1001/JAMAPEDIATRICS.2021.0541
Jiehao C, Jin X, Daojiong L, et al. A case series of children with 2019 novel coronavirus infection: Clinical and epidemiological features. Clin Infect Dis. 2020;71(6):1547-1551. doi: 10.1093/cid/ciaa198
Park Y, Choe Y, Park O, et al. Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020. Emerg Infect Dis. 2020;26(10). doi: 10.3201/EID2610.201315
Preston LE, Chevinsky JR, Kompaniyets L, et al. Characteristics and Disease Severity of US Children and Adolescents Diagnosed With COVID-19. JAMA Netw Open. 2021;4(4):e215298-e215298. doi: 10.1001/JAMANETWORKOPEN.2021.5298
COVAXIN in a Pediatric Cohort - Full Text View - ClinicalTrials.gov. Accessed August 9, 2021. https://clinicaltrials.gov/ct2/show/NCT04918797
Kumar VM, Pandi-Perumal SR, Trakht I, Thyagarajan SP. Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases. npj Vaccines. 2021;6(1). doi: 10.1038/s41541-021-00327-2